Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Journal . 2025
License: CC BY NC ND
Data sources: ZENODO
ZENODO
Journal . 2025
License: CC BY NC ND
Data sources: Datacite
ZENODO
Journal . 2025
License: CC BY NC ND
Data sources: Datacite
 View all 2 versions
Claim

Boletín Fármacos: Agencias Reguladoras 2025; 28(4)

descriptionPublicationkeyboard_double_arrow_right Journal 26 Nov 2025 Spanish Publisher:Salud y Fármacos
Authors: Salud y Fármacos; Homedes, Nuria; Ugalde, Antonio; Castrillon Valencia, Natalia Katerine;

doi: 10.5281/zenodo.17724274 , 10.5281/zenodo.17724273

Boletín Fármacos: Agencias Reguladoras 2025; 28(4)

Abstract

Boletín Fármacos es un boletín electrónico de la organización Salud y Fármacos (https://www.saludyfarmacos.org/) que se publica cuatro veces al año. El "Boletín Fármacos: Agencias Reguladoras" incluye información sobre el desempeño de las agencias reguladoras en materia de medicamentos, tanto las de países de altos ingresos como las de países de medianos y bajos ingresos. Este documento corresponde al 2025, Vol. 28, N°4.

Keywords

Regulación internacional, América Latina, EMA, Medicamentos, Regulación de medicamentos en países de altos ingresos, agencias reguladoras, Regulación de medicamentos en países de medianos y bajos ingresos, FDA

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    		 Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    		 Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Green